Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

Abroad (travel likely)Recruiting

Conditions

Stroke · Coronary Arterial Disease (CAD) · Myocardial Infarction (MI) · Diabetes Mellitus · Peripheral Artery Disease (PAD) · Chronic Kidney Disease(CKD) · Albuminuria

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Unidade Local de Saúde de São João, Porto, Portugal
Contact: Study coordinator (Francisca Saraiva, PhD) · f.saraiva@med.up.pt · 225512100
Contact: Principal Investigator (João Pedro Ferreira, MD, PhD)

Study leads

João Pedro Ferreira, MD, PhD
Principal Investigator
Universidade do Porto

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Diabetes Mellitus, Type 2 · Stroke (CVA) or Transient Ischemic Attack

Abroad (travel likely)RecruitingPHASE4

Seattle, United States

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

SARS- CoV-2 · Cardiovascular Diseases · Chronic Kidney Diseases

Abroad (travel likely)Recruiting

Columbia, United States

Optimizing Reperfusion to Improve Outcomes and Neurologic Function

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2, PHASE3

Long Beach, United States · Sacramento, United States

Acetyl-leucine in Post-stroke Ataxia

Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Kafr ash Shaykh, Egypt